Kunath, Frank and Heidegger, Isabel and Heck, Matthias and Mayr, Roman and Becker, Christoph and Rausch, Steffen (2024) Molecular tumor boards in uro-oncology-prostate cancer. UROLOGIE, 63 (9). pp. 899-907. ISSN 2731-7064, 2731-7072
Full text not available from this repository. (Request a copy)Abstract
The rapid development of molecular medicine has opened up new perspectives for the diagnosis and treatment of urological tumors. Urology faces the challenge of effectively treating advanced cancer, especially in view of the genetic diversity of urological tumors. The molecular tumor board offers an innovative approach to identify targeted therapy options based on the individual genetic signatures of tumor cells or tumor microenvironment-based treatment options. In this article, the concept of the molecular tumor board in urology is presented using the example of prostate cancer. We discuss the principles, applications, and future prospects of this promising approach.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ABIRATERONE; AR-V7; PREDNISOLONE; CELLS; Molecular pathology; Molecular profiling; Biomarkers; Therapeutic targets; Relevant studies; Molecular pathology; Molecular profiling; Biomarkers; Therapeutic targets; Relevant studies |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Urologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 16 Jan 2026 11:08 |
| Last Modified: | 16 Jan 2026 11:08 |
| URI: | https://pred.uni-regensburg.de/id/eprint/65124 |
Actions (login required)
 |
View Item |
